Your browser doesn't support javascript.
loading
Multiplexed imaging of tumor immune microenvironmental markers in locally advanced or metastatic non-small-cell lung cancer characterizes the features of response to PD-1 blockade plus chemotherapy.
Wu, Fengying; Jiang, Tao; Chen, Gongyan; Huang, Yunchao; Zhou, Jianying; Lin, Lizhu; Feng, Jifeng; Wang, Zhehai; Shu, Yongqian; Shi, Jianhua; Hu, Yi; Wang, Qiming; Cheng, Ying; Chen, Jianhua; Lin, Xiaoyan; Wang, Yongsheng; Huang, Jianan; Cui, Jiuwei; Cao, Lejie; Liu, Yunpeng; Zhang, Yiping; Pan, Yueyin; Zhao, Jun; Wang, LiPing; Chang, Jianhua; Chen, Qun; Ren, Xiubao; Zhang, Wei; Fan, Yun; He, Zhiyong; Fang, Jian; Gu, Kangsheng; Dong, Xiaorong; Zhang, Tao; Shi, Wei; Zou, Jianjun; Bai, Xuejuan; Ren, Shengxiang; Zhou, Caicun.
  • Wu F; Department of Thoracic Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, 200433, P. R. China.
  • Jiang T; Department of Thoracic Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, 200433, P. R. China.
  • Chen G; Department of Respiratory Medicine, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, 150000, P. R. China.
  • Huang Y; Department of Thoracic Surgery Oncology, Yunnan Cancer Hospital & The Third Affiliated Hospital of Kunming Medical University & Yunnan Cancer Center, Kunming, Yunnan, 650118, P. R. China.
  • Zhou J; Department of Respiratory Medicine, The First Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang, 310009, P. R. China.
  • Lin L; Department of Oncology Center, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510405, P. R. China.
  • Feng J; Department of Thoracic Medical Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210009, P. R. China.
  • Wang Z; Department of Respiratory, Shandong Cancer Hospital & Institute, Jinan, Shandong, 250117, P. R. China.
  • Shu Y; Department of Oncology, Jiangsu Province Hospital, Nanjing, Jiangsu, 210000, P. R. China.
  • Shi J; Department of Medical Oncology, Linyi Cancer Hospital, Linyi, Shandong, 276000, P. R. China.
  • Hu Y; Department of Oncology, Chinese PLA General Hospital, Beijing, 100853, P. R. China.
  • Wang Q; Department of Respiratory Medicine, Henan Cancer Hospital, Zhengzhou, Henan, 450000, P. R. China.
  • Cheng Y; Department of Thoracic Oncology, Jilin Cancer Hospital, Changchun, Jilin, 130012, P. R. China.
  • Chen J; Department of Medical Oncology-Chest, Hunan Cancer Hospital, Changsha, Hunan, 410006, P. R. China.
  • Lin X; Department of Oncology, Fujian Medical University Union Hospital, Fuzhou, Fujian, 350001, P. R. China.
  • Wang Y; Department of Thoracic Medical Oncology, West China Hospital, Sichuan University, Chengdu, Sichuan, 610000, P. R. China.
  • Huang J; Department of Respiration, First Affiliated Hospital of Suzhou University, Suzhou, Jiangsu, 215002, P. R. China.
  • Cui J; Department of Medical Oncology, The First Bethune Hospital of Jilin University, Changchun, Jilin, 130021, P. R. China.
  • Cao L; Pulmonary and Critical Care Medicine, The First Affiliated Hospital University of Science Technology of China, Hefei, Anhui, 230036, P. R. China.
  • Liu Y; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, Liaoning, 110000, P. R. China.
  • Zhang Y; Thoracic Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, 310022, P. R. China.
  • Pan Y; Department of Tumor Chemotherapy, The First Affiliated Hospital University of Science Technology of China, Hefei, Anhui, 230036, P. R. China.
  • Zhao J; Department of Thoracic Medical Oncology, Peking University Cancer Hospital & Institute, Beijing, 100142, P. R. China.
  • Wang L; Department of Medical Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450000, P. R. China.
  • Chang J; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China.
  • Chen Q; Department of Oncology, Fuzhou Pulmonary Hospital of Fujian, Fuzhou, Fujian, 350008, P. R. China.
  • Ren X; Department of Biotherapy, Tianjin Medical University Cancer Institute & Hospital, Tianjin, 300060, P. R. China.
  • Zhang W; Pneumology Department, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 330006, P. R. China.
  • Fan Y; Department of Thoracic Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, 310022, P. R. China.
  • He Z; Department of Thoracic Oncology, Fujian Cancer Hospital, Fuzhou, Fujian, 350000, P. R. China.
  • Fang J; Department of Thoracic Oncology II, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing) Peking University Cancer Hospital & Institute, Beijing, 100142, P. R. China.
  • Gu K; Department of Medical Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230031, P. R. China.
  • Dong X; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, P. R. China.
  • Zhang T; Clinical Research & Development, Jiangsu Hengrui Medicine Co. Ltd, Shanghai, 201210, P. R. China.
  • Shi W; Clinical Research & Development, Jiangsu Hengrui Medicine Co. Ltd, Shanghai, 201210, P. R. China.
  • Zou J; Clinical Research & Development, Jiangsu Hengrui Medicine Co. Ltd, Shanghai, 201210, P. R. China.
  • Bai X; Genecast Biotechnology Co., Ltd, Wuxi, Jiangsu, 214100, P. R. China.
  • Ren S; Department of Thoracic Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, 200433, P. R. China.
  • Zhou C; Department of Thoracic Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, 200433, P. R. China.
Cancer Commun (Lond) ; 42(12): 1331-1346, 2022 12.
Article en En | MEDLINE | ID: mdl-36331328
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article